In 2016, the global medical device company TOP100 was released

The title of the world's largest medical device company has long been occupied by Johnson & Johnson. After more than a year of the largest mergers and acquisitions in the history of the medical device industry , Medtronic finally replaced Johnson & Johnson in the world's number one position - at least from the sales data. At this time last year, because Medtronic’s earnings only included the income of the latter’s last fiscal quarter after the acquisition of Ke Hui, it was still inferior to Johnson’s income. This year, after all of Kehui’s full fiscal year’s revenues were included, Medtronic’s total medical device-related revenue for fiscal year 2016 reached $28.82 billion – a 42% increase from last year’s, compared to Johnson’s medical care this year. Device-related income was $3 billion more. Since Johnson & Johnson sold Ortho-Clinical Diagnostics and Cordis in 2015, its total medical device-related revenue in 2015 fell to $25.14 billion from $27.52 billion in 2014.

Of course, the location changes not only in the first and second place. In addition to GE Healthcare and Siemens Healthcare continue to maintain their third and fourth positions, the top 10 of the list has changed from last year.

Both Kantler and Danaher have risen two places from last year. BD Medical, from the 13th place of last year, rose to 4th place - the first time into the Top 10 camp. Similar to Medtronic, BD Medical's superior performance on the list benefited from a huge acquisition, a $12.2 billion acquisition of drug management and patient care company CareFusion, completed in March 2015. BD Healthcare's fiscal year 2016 ends on September 30, 2016, and the results include revenue for the first full fiscal year since the acquisition of CareFusion – which in turn increased the company's fiscal year 2016 revenues related to medical devices to 99.6. Billions of dollars, more than $2.2 billion more than the fiscal year 2015.

Philips Medical, Roche Diagnostics and Stryker have dropped their rankings from last year. In fact, Philips and Stryker did record growth in their income, only because they were squeezed by several companies that rose in the above rankings. Siemens is also affected by the negative impact of the exchange rate and its ongoing business restructuring plan.

Abbott fell out of the top 10 this year and turned to the 11th place. Abbott’s medical device-related revenue for fiscal year 2015 fell to $9.71 billion from $10.18 billion in fiscal 2014 due to negative impacts on market diagnostics and medical device sales outside the US. Moreover, for Abbott, which has always favored acquisitions, 2015 was quite calm and did not enjoy the additional revenue growth from any acquisition. However, in 2016, Abbott took action on the acquisition and took the income of St. Jude Medical (17th in MTI 100). As early as February of this year, Abbott also announced that it will acquire US Airil (MTI 100 32nd), but after a series of evaluations on the latter's financial and regulatory issues, Abbott announced on December 7. The acquisition was cancelled and the termination process was initiated.

Another notable name in this year's list is LivaNova, a merger of Sorin and Cybernonics. Sorin and Cybernonics were ranked 58 and 93 respectively - after the merger, LivaNova ranked 70th this year. The two companies have been flat since the merger, and investors are not satisfied with this. Their ranking on the list is likely to decline in the next year.

A merger of companies means that there are vacancies left to companies that were previously outside the Top 100. Companies entering the MTI 100 for the first time this year include: Quidel, Accuray, Consort Medical, Cardiovascular Systems, InvaCare, STratec Biomedical Systems, Endologix, Meridian Bioscience and Sectra.